Women’s Health & Gynecology: Cannabinoid Research Clinician Packet (Nationwide Edition)

A 12-page, doctor-facing summary of what published research and professional guidance say about cannabis and cannabinoids in women's health, with pregnancy and breastfeeding safety covered first.

Includes:

• Menopause symptoms, endometriosis and pelvic pain, dysmenorrhea, PMS/PMDD, vulvodynia and sexual health
• Pregnancy and breastfeeding safety (ACOG, AAP, CDC and FDA guidance)
• An evidence-at-a-glance table
• Medicines to flag for pharmacist review
• A patient-conversation checklist
• A 50-state + DC program table (NCSL, current as of October 2026)

Same clean format, 54 sources, 44 verified PubMed records, same rules: no doses, no product recommendations.

Education only. These guides are a research-navigation aid. They are not medical, legal or prescribing advice. They do not diagnose, prescribe, recommend products, set doses or titration, or give drug-interaction verdicts. Findings are summarized for orientation only. Read the original sources before relying on any of them. Clinical decisions remain with the treating clinician. Confirm all laws and program rules on official state sites. For use with licensed, state-regulated medical cannabis programs and FDA-approved drugs only.

Sources include the American College of Obstetricians and Gynecologists (ACOG), the CDC, the American Academy of Pediatrics (AAP), FDA drug labels and advisories, the National Academies of Sciences, Engineering, and Medicine (2017), Cochrane reviews, studies indexed in PubMed, the National Conference of State Legislatures (NCSL), and official state program sites. This is an independent guide and is not endorsed by any cited source. Prepared by Annie Romelfanger, author of Medical Cannabis Handbook: A Friendly Guide to Safe, Simple Healing. Last reviewed: October 2026. Corrections: romelfanger@proton.me.